Dr. Eleni Magira, MD, PhD, is a distinguished Professor in the 1st Department of Critical Care at Evangelismos Hospital, National and Kapodistrian University of Athens, Greece. With extensive experience in internal medicine and critical care, she is an accomplished researcher, educator, and medical practitioner dedicated to advancing immunogenetics and infectious disease care.
Profile
Google Scholar
🎓 Education
- MD (1996): Aristotle University of Thessaloniki Medical School, Greece.
- PhD (2008): University of Athens Medical School. Thesis: Immunogenetics aspects of Pulmonary Tuberculosis in the Greek Population.
💼 Experience
- 1996-1997: General Physician, Primary Care Center, Greece.
- 1998-2000: Post-Doctoral Fellow, Immunogenetics Lab, University of Pennsylvania, USA.
- 2000-2005: Resident in Internal Medicine, Evangelismos General Hospital, Athens.
- 2017-2018: Fulbright Visiting Scholar, MD Anderson Cancer Center, Texas, USA.
- 2024-Present: Professor, Evangelismos Hospital, University of Athens.
🔬 Research Interests
- Immunogenetics of infectious diseases, particularly pulmonary tuberculosis.
- Fungal infections and their intersection with SARS-CoV-2.
- Clinical epidemiology of invasive pulmonary aspergillosis in immunocompromised patients.
🏆 Awards
- 2002: Travel Award, Federation of European Societies of Chemotherapy and Infection.
- 2004: Travel Award, American Society of Histocompatibility and Immunogenetics.
- 2002-2004: Recognition for contributions in immunogenetics and histocompatibility research.
📚 Publications Top Notes:
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study
HLA-DRB1* 1101: a significant risk factor for sarcoidosis in blacks and whites
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study
Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19
Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: studies in 8 stuporous and comatose patients
Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity
Relationship between ventilator-associated pneumonia and mortality in COVID-19 patients: a planned ancillary analysis of the coVAPid cohort
Differential distribution of HLA-DQβ/DRβ epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy …
Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study